BNET Industries
Market Cap:$12.7B
Last Fiscal Year Sales:$3.7B
- Public
- US
Dow Jones Description
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. Headquartered in St. Paul, Minn., St. Jude Medical employs approximately 14,000 people worldwide and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, electrophysiology catheters, mapping and visualization systems, vascular closure devices, heart valve replacement and repair products, and neurostimulation devices.
Number of Employees 14,000
Peer Companies
NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
Recent Events
-
St. Jude's Stock Is No Hopeless Cause
-
St. Jude Medical Gets FDA Nod For Penta Surgical Lead To Manage Chronic Pain -...
-
SJM Releases New Neurostimulator Programming Software
-
Morgan Joseph Initiates Coverage on St. Jude Medical STJ with a Buy; High-Quality Name in...
-
UPDATE: St. Jude Leaves Trade Group AdvaMed In Tax Dispute
-
Zacks Analyst Blog Highlights: Morgan Stanley, Goldman Sachs, St.
-
Was the St. Jude sell-off overdone?
-
Canaccord Adams Downgrades St. Jude Medical Inc. STJ to Hold
-
David Moenning's Daily State of the Markets: Voting With Their Feet
-
Edwards Lifesciences Q3 Profit More Than Doubles; Updates FY09 Outlook
-
Uncertainty in face of reform
-
St. Jude Medical Announces Australian Launch of Devices that Diagnose and Treat Abnormal Heart Rhythms
-
Zacks Analyst Blog Highlights: Fannie Mae, Freddie Mac, St. Jude Medical, Medtronic and Boston...
-
Micell gets investment from St. Jude Medical
-
$15 million infusion for Micell
-
St. Jude Medical to Showcase Complete Cardiovascular Access, Intervention and Hemostasis...
-
St. Jude Medical Announces European Launch of New Version of
-
St. Jude Medical Announces European Launch of New Version of Remote Patient Care Network
News & Analysis
Filter by
ide and st. jude medical inc. - All News and Analysis
St. Jude Medical Announces IDE Approval to begin ESCAPE Migraine Study
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) announced today that it has received conditional approval from the U.S. Food and Drug Administration FDA of an Investigational Device Exemption IDE to begin enrollment in the ESCAPE (Effect of Septal Closure of Atrial PFO on Events of Migraine with PremereTM)...
St. Jude Medical Announces IDE Approval and First Implant of the QuickSite 1056T Bipolar CRT Lead
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) announced today that it has received an Investigational Device Exemption IDE from the U.S. Food and Drug Administration FDA authorizing enrollment in the fourth phase of the RHYTHM ICD Study, which is evaluating the QuickSiteR 1056T bipolar left-heart pacing lead, the...
St. Jude Medical Announces IDE Approval and First Implants of the QuickSite Left Heart Pacing Lead
Business Editors/Health/Medical Writers
- 1
Industry Transcripts by Seeking Alpha
-
Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about CMN
-
The Cooper Companies, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about COO
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
